1Cockayne S, Adamson J, Lanham-New S, et al. (2006) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166, 1256–1261.
2Beulens JW, Bots ML, Atsma F, et al. (2009) High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 203, 489–493.
3Geleijnse JM, Vermeer C, Grobbee DE, et al. (2004) Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 134, 3100–3105.
4Spronk HM, Soute BA, Schurgers LJ, et al. (2003) Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 40, 531–537.
5Australian National Health and Medical Research Council, New Zealand Ministry of Health (2005) Vitamin K. Nutrient Reference Values for Australia and New Zealand, pp. 147–151. Canberra: Commonwealth of Australia.
6FAO Rome Food and Nutrition Division (2001) Vitamin K. Human Vitamin and Mineral Requirements: Report of a Joint FAO/WHO Expert Consultation, Bangkok, Thailand, pp. 133–150. Rome: FAO.
7National Research Council (2000) Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press.
8EFSA Panel on Dietetic Products, Nutriton and Allergies (NDA) (2010) Scientific Opinion on principles for deriving and applying Dietary Reference Values. EFSA J 8, 1458.
9Shearer MJ & Newman P (2008) Metabolism and cell biology of vitamin K. Thromb Haemost 100, 530–547.
10Collins MD & Jones D (1981) Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication. Microbiol Rev 45, 316–354.
11Booth SL & Suttie JW (1998) Dietary intake and adequacy of vitamin K. J Nutr 128, 785–788.
12Thijssen HH, Vervoort LM, Schurgers LJ, et al. (2006) Menadione is a metabolite of oral vitamin K. Br J Nutr 95, 260–266.
13Schurgers LJ, Teunissen KJ, Hamulyak K, et al. (2007) Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 109, 3279–3283.
14Rishavy MA & Berkner KL (2012) Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv Nutr 3, 135–148.
15McCann JC & Ames BN (2009) Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 90, 889–907.
16Schurgers LJ & Vermeer C (2000) Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 30, 298–307.
17Bolton-Smith C, Price RJ, Fenton ST, et al. (2000) Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr 83, 389–399.
18Shearer MJ & Bolton-Smith C (2000) The UK food data-base for vitamin K and why we need it. Food Chem 68, 213–218.
19Nimptsch K, Rohrmann S & Linseisen J (2008) Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 87, 985–992.
20Kamao M, Suhara Y, Tsugawa N, et al. (2007) Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol (Tokyo) 53, 464–470.
21Fox PF & McSweeney PLH (2004) Cheese: an overview. In Cheese Chemistry, Physics and Microbiology, 1st vol., 3rd ed., pp. 1–18 [PF Fox, PLH McSweeney, TM Cogan and TP Guinee, editors]. London: Elsevier Academic Press.
22Beulens JW, Van der A D, Grobbee DE, et al. (2010) Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 33, 1699–1705.
23Gast GC, de Roos NM, Sluijs I, et al. (2009) A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 19, 504–510.
24Elder SJ, Haytowitz DB, Howe J, et al. (2006) Vitamin k contents of meat, dairy, and fast food in the U.S. Diet. J Agric Food Chem 54, 463–467.
25Bresson JL, Flynn A, Heinonen M, et al. (2008) Vitamin K2 added for nutritional purpose in foods for particular nutritional uses, food supplements and foods intended for the general population. EFSA J 822, 1–31.
26Gijsbers BL, Jie KS & Vermeer C (1996) Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr 76, 223–229.
27Sato T, Schurgers LJ & Uenishi K (2012) Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J 11, 93.
28Novotny JA, Kurilich AC, Britz SJ, et al. (2010) Vitamin K absorption and kinetics in human subjects after consumption of 13C-labelled phylloquinone from kale. Br J Nutr 104, 858–862.
29Schurgers LJ & Vermeer C (2002) Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta 1570, 27–32.
30AL Rajaba A, Booth SL, Peterson JW, et al. (2012) Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J Nutr 142, 841–845.
31Ronden JE, Thijssen HH & Vermeer C (1998) Tissue distribution of K-vitamers under different nutritional regimens in the rat. Biochim Biophys Acta 1379, 16–22.
32Thijssen HH & Drittij-Reijnders MJ (1994) Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr 72, 415–425.
33Fu X, Peterson JW, Hdeib M, et al. (2009) Measurement of deuterium-labeled phylloquinone in plasma by high-performance liquid chromatography/mass spectrometry. Anal Chem 81, 5421–5425.
34Jones KS, Bluck LJ, Wang LY, et al. (2008) A stable isotope method for the simultaneous measurement of vitamin K1 (phylloquinone) kinetics and absorption. Eur J Clin Nutr 62, 1273–1281.
35Jones KS, Bluck LJ, Wang LY, et al. (2009) The effect of different meals on the absorption of stable isotope-labelled phylloquinone. Br J Nutr 102, 1195–1202.
36Nowicka B & Kruk J (2010) Occurrence, biosynthesis and function of isoprenoid quinones. Biochim Biophys Acta 1797, 1587–1605.
37Fernandez F & Collins MD (1987) Vitamin-K composition of anaerobic gut bacteria. FEMS Microbiol Lett 63, 175–180.
38Hill MJ (1997) Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 6, Suppl. 1, S43–S45.
39Mathers JC, Fernandez F, Hill MJ, et al. (1990) Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats. Br J Nutr 63, 639–652.
40Morishita T, Tamura N, Makino T, et al. (1999) Production of menaquinones by lactic acid bacteria. J Dairy Sci 82, 1897–1903.
41Hojo K, Watanabe R, Mori T, et al. (2007) Quantitative measurement of tetrahydromenaquinone-9 in cheese fermented by propionibacteria. J Dairy Sci 90, 4078–4083.
42Conly JM & Stein K (1992) The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis. Prog Food Nutr Sci 16, 307–343.
43Suttie JW (1995) The importance of menaquinones in human nutrition. Annu Rev Nutr 15, 399–417.
44Duello TJ & Matschiner JT (1972) Characterization of vitamin K from human liver. J Nutr 102, 331–335.
45Usui Y, Tanimura H, Nishimura N, et al. (1990) Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 51, 846–852.
46Olson RE (1984) The function and metabolism of vitamin K. Annu Rev Nutr 4, 281–337.
47Conly JM & Stein K (1992) Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol 87, 311–316.
48Ichihashi T, Takagishi Y, Uchida K, et al. (1992) Colonic absorption of menaquinone-4 and menaquinone-9 in rats. J Nutr 122, 506–512.
49Fujita K, Kakuya F & Ito S (1993) Vitamin K1 and K2 status and faecal flora in breast fed and formula fed 1-month-old infants. Eur J Pediatr 152, 852–855.
50Ramotar K, Conly JM, Chubb H, et al. (1984) Production of menaquinones by intestinal anaerobes. J Infect Dis 150, 213–218.
51Booth SL & AL Rajaba A (2008) Determinants of vitamin K status in humans. Vitam Horm 78, 1–22.
52AL Rajaba A, Peterson J, Choi SW, et al. (2010) Measurement of menadione in urine by HPLC. J Chromatogr B Analyt Technol Biomed Life Sci 878, 2457–2460.
53Harrington DJ, Booth SL, Card DJ, et al. (2007) Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 137, 1763–1768.
54Bruge F, Bacchetti T, Principi F, et al. (2011) Olive oil supplemented with menaquinone-7 significantly affects osteocalcin carboxylation. Br J Nutr 106, 1058–1062.
55Harrington DJ, Soper R, Edwards C, et al. (2005) Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 46, 1053–1060.
56Suttie JW (1992) Vitamin K and human nutrition. J Am Diet Assoc 92, 585–590.
57Schurgers LJ, Shearer MJ, Hamulyak K, et al. (2004) Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose–response relationships in healthy subjects. Blood 104, 2682–2689.
58Frick PG, Riedler G & Brogli H (1967) Dose response and minimal daily requirement for vitamin K in man. J Appl Physiol 23, 387–389.
59Suttie JW, Mummah-Schendel LL, Shah DV, et al. (1988) Vitamin K deficiency from dietary vitamin K restriction in humans. Am J Clin Nutr 47, 475–480.
60Udall JA (1965) Human sources and absorption of vitamin K in relation to anticoagulation stability. JAMA 194, 127–129.
61Booth SL, Lichtenstein AH, O'Brien-Morse M, et al. (2001) Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 74, 783–790.
62Booth SL, Martini L, Peterson JW, et al. (2003) Dietary phylloquinone depletion and repletion in older women. J Nutr 133, 2565–2569.
63Furukawa M, Nakanishi T, Okuda H, et al. (1992) Changes of plasma des-gamma-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K. Cancer 69, 31–38.
64Emaus N, Gjesdal CG, Almas B, et al. (2010) Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int 21, 1731–1740.
65Tsukamoto Y, Ichise H, Kakuda H, et al. (2000) Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals. J Bone Miner Metab 18, 216–222.
66van Summeren MJ, Braam LA, Lilien MR, et al. (2009) The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr 102, 1171–1178.
67Cranenburg EC, Koos R, Schurgers LJ, et al. (2010) Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 104, 811–822.
68Dalmeijer GW, van der Schouw YT, Magdeleyns E, et al. (2012) The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis 225, 397–402.
69Theuwissen E, Cranenburg EC, Knapen MH, et al. (2012) Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 108, 1652–1657.
70Westenfeld R, Krueger T, Schlieper G, et al. (2012) Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59, 186–195.
71Greenland P, Bonow RO, Brundage BH, et al. (2007) ACCF/AHA clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49, 378–402.
72Shanahan CM, Proudfoot D, Farzaneh-Far A, et al. (1998) The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr 8, 357–375.
73Maas AH, van der Schouw YT, Beijerinck D, et al. (2007) Vitamin K intake and calcifications in breast arteries. Maturitas 56, 273–279.
74Booth SL (1997) Skeletal functions of vitamin K-dependent proteins: not just for clotting anymore. Nutr Rev 55, 282–284.
75Booth SL, Tucker KL, Chen H, et al. (2000) Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71, 1201–1208.
76Jie KG, Bots ML, Vermeer C, et al. (1996) Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 59, 352–356.
77Kaneki M, Hodges SJ, Hosoi T, et al. (2001) Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17, 315–321.
78Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, et al. (1998) Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63, 375–379.
79Luukinen H, Kakonen SM, Pettersson K, et al. (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15, 2473–2478.
80Schaafsma A, Muskiet FA, Storm H, et al. (2000) Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr 54, 626–631.
81Sugiyama T & Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19, 146–149.
82Szulc P, Chapuy MC, Meunier PJ, et al. (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91, 1769–1774.
83Szulc P, Arlot M, Chapuy MC, et al. (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9, 1591–1595.
84Szulc P, Chapuy MC, Meunier PJ, et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18, 487–488.
85Vergnaud P, Garnero P, Meunier PJ, et al. (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82, 719–724.
86Kalkwarf HJ, Khoury JC, Bean J, et al. (2004) Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 80, 1075–1080.
87O'Connor E, Molgaard C, Michaelsen KF, et al. (2007) Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br J Nutr 97, 661–666.
88van Summeren M, van Coeverden SC, Schurgers LJ, et al. (2008) Vitamin K status is associated with childhood bone mineral content. Br J Nutr 100, 852–858.
89van SM, Braam L, Noirt F, et al. (2007) Pronounced elevation of undercarboxylated osteocalcin in healthy children. Pediatr Res 61, 366–370.
90Hodges SJ, Pilkington MJ, Stamp TC, et al. (1991) Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12, 387–389.
91Hodges SJ, Akesson K, Vergnaud P, et al. (1993) Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8, 1241–1245.
92Kanai T, Takagi T, Masuhiro K, et al. (1997) Serum vitamin K level and bone mineral density in post-menopausal women. Int J Gynaecol Obstet 56, 25–30.
93Tamatani M, Morimoto S, Nakajima M, et al. (1998) Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism 47, 195–199.
94Tsugawa N, Shiraki M, Suhara Y, et al. (2008) Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26, 79–85.
95Katsuyama H, Ideguchi S, Fukunaga M, et al. (2004) Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women. J Nutr Sci Vitaminol (Tokyo) 50, 114–120.
96Kanellakis S, Moschonis G, Tenta R, et al. (2012) Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II. Calcif Tissue Int 90, 251–262.
97Katsuyama H, Ideguchi S, Fukunaga M, et al. (2002) Usual dietary intake of fermented soybeans (Natto) is associated with bone mineral density in premenopausal women. J Nutr Sci Vitaminol (Tokyo) 48, 207–215.
98Ikeda Y, Iki M, Morita A, et al. (2006) Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J Nutr 136, 1323–1328.
99Apalset EM, Gjesdal CG, Eide GE, et al. (2010) Dietary vitamins K1, K2 and bone mineral density: The Hordaland Health Study. Arch Osteopor 5, 73–81.
100Lips P (2010) Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 121, 297–300.
101Apalset EM, Gjesdal CG, Eide GE, et al. (2011) Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone 49, 990–995.
102Shearer MJ (2009) Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 23, 49–59.
103Pucaj K, Rasmussen H, Moller M, et al. (2011) Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7. Toxicol Mech Methods 21, 520–532.
104Ronden JE, Groenen-van Dooren MM, Hornstra G, et al. (1997) Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains. Atherosclerosis 132, 61–67.
105Hemker HC, AL Dieri R, De Smeat E, et al. (2006) Thrombin generation, a function test of the haemostatic–thrombotic system. Thromb Haemost 96, 553–561.
106Holmes MV, Hunt BJ & Shearer MJ (2012) The role of dietary vitamin K in the management of oral vitamin K antagonists. Blood Rev 26, 1–14.
107Bunyaratavej N, Penkitti P, Kittimanon N, et al. (2001) Efficacy and safety of menatetrenone-4 postmenopausal Thai women. J Med Assoc Thai 84, Suppl. 2, S553–S559.